Revolutionizing
Drug Discovery
Real-time insights.
Eliminate guesswork.
Cancer adapts. Drug discovery hasn't—until now.
Precigenetics' platform taps into real-time epigenetic changes, unlocking new frontiers in precision medicine and targeted therapies.
COMPASS, our proprietary spectral intelligence platform, uncovers how cells regulate and adapt in real time, providing unprecedented insight into epigenetic mechanisms that drive disease and treatment response.
Real-time Analysis
Enables real-time single-cell analysis of epigenetic changes.
Non-destructive Insights
Provides non-destructive biological insights preserving cell integrity.
Accelerated Discovery
Accelerates discovery timelines with immediate biological feedback.
High-throughput Scale
Scales effectively for high-throughput applications and screening.
Our Capabilities
Precigenetics' proprietary optical technologies directly visualize epigenetic changes without damaging cells, unlocking rapid, actionable therapeutic insights. By eliminating guesswork, we empower researchers and clinicians to address diseases accurately and effectively, beginning with transformative applications in precision oncology.
Precision Oncology
Direct optical analysis of epigenetic markers, accelerating targeted therapies.
Single-Cell Epigenetics
Visualizing individual cell behaviors and disease pathways with clarity.
Computational Biology
Analyzing biological complexity with computational precision.
Blog & News
Updates on research, milestones, and strategic insights from our team